Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food and Drug ...

MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.

The USFDA has approved Lipfendra, the first oral PCSK9 inhibitor, for lowering LDL cholesterol. The once-daily pill could improve long-term adherence, though Indian access will depend on approval and ...

A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...

With enlicitide, large LDL reductions possible without a needle ...

The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...

H.R. 875 – Jeremy and Angel Seay and Sergeant Brandon Mendoza Protect Our Communities from DUIs Act of 2025 (June 24, 2025) H.R. 275 – Special Interest Alien Reporting Act of 2025 (June 24, 2025) S.J.

The undergraduate degree in business administration allows students to tailor their degree to meet their interests and career goals by specializing in one of 10 areas of emphasis. You can do a lot ...

Of all of President Roosevelt’s New Deal programs, the Works Progress Administration (WPA) is the most famous, because it affected so many people’s lives. Roosevelt’s work-relief program employed more ...

Millions of adults whose cholesterol stays dangerously high despite taking statins now have a new option that does not ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas ...